EYE 2.17% 23.5¢ nova eye medical limited

Ann: Full Year Financial Results, page-141

  1. 802 Posts.
    lightbulb Created with Sketch. 136
    What an absolute stunning report!

    Look at that gross margin grow since fy23 67%, 1h24 69 %(included slow down due to LCD concerns), 2h24 73%. And check out the opex growth relative to sales growth from fy23. This trajectory will clearly get us to CF positive very soon.

    They have never provided forward guidance from the many many years I have been invested. But with this report, you can clearly see with the actual numbers they are delivering, that they are confident in further growth.

    When I look back at the journey from the original iTrack back in 2015/2016, this time definitely seems to be different e.g. initial US growth was around 20-30% yoy Vs the 70%+ we are seeing now. I.e. the original iTrack was just too cumbersome to perform Vs iTrack advance. This also answers someone's question about growth from 2021 i.e. it's a completely different device now.

    i have not seen these strong statements from Nova Eye in the past e.g. on slide 1 where they talk about execution.

    July materially up yoy!

    Analyst, I remember those lonely years back in 2021, 2022 after the laser sale, where there were only a few posters, yourself, maybe I chipped in and also hatmopit and a couple of others. But this intelligent management team and the key opinion leaders have taken this device to another level!!
    Last edited by DBrent15: Yesterday, 19:49
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $53.82M
Open High Low Value Volume
24.5¢ 25.0¢ 22.0¢ $231.2K 989.5K

Buyers (Bids)

No. Vol. Price($)
4 91844 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 70000 2
View Market Depth
Last trade - 14.54pm 26/08/2024 (20 minute delay) ?
EYE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.